Duality Advisers, LP Bridge Bio Pharma, Inc. Transaction History

Duality Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$27.35 - $40.45 $178,130 - $263,450	-6,513 Reduced 8.12%	73,679 $2.28 Million
Q4 2023 Feb 01, 2024	BUY	$24.02 - $43.89 $745,484 - $1.36 Million	31,036 Added 63.14%	80,192 $3.24 Million
Q3 2023 Nov 02, 2023	BUY	$16.89 - $35.01 $830,244 - $1.72 Million	49,156 New	49,156 $1.3 Million
Q1 2023 Jun 27, 2023	BUY	$7.17 - $18.55 $300,939 - $778,580	41,972 New	41,972 $695,000
Q1 2022 May 09, 2022	SELL	$7.34 - $17.16 $1.59 Million - $3.71 Million	-216,254 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$11.38 - $53.41 $2.05 Million - $9.63 Million	180,298 Added 501.44%	216,254 $3.61 Million
Q3 2021 Nov 08, 2021	BUY	$46.87 - $64.24 $476,855 - $653,577	10,174 Added 39.46%	35,956 $1.69 Million
Q2 2021 Aug 09, 2021	BUY	$46.47 - $63.93 $1.2 Million - $1.65 Million	25,782 New	25,782 $1.57 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.